Speciality Medicines IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Listed
SME IPO
SPECIALITYMEDICINES
Speciality Medicines
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
Current GMP Status
₹0
+0% vs upper band
Est. Listing Gain
+0.00%
Last Trend
26 Mar 2026
Listing Price
₹124.00
Retail Entry
₹2,48,000
IPO Details
Complete IPO information
| Current GMP | ₹0 |
|---|---|
| Estimated Listing Gain | +0.00% |
| Price Band | ₹117.00 - ₹124.00 |
| Issue Price | ₹124.00 |
| Listing Price | ₹124.00 |
| Lot Size | 1,000 Shares |
| Issue Type | SME |
| Issue Size | TBA |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | 2.27x |
| Listing Date | 30 Mar 2026 |
| Minimum Investment | ₹2,48,000 |
Timeline
IPO roadmap at a glance
✓
Bidding Opens
20 Mar 2026
✓
Bidding Closes
24 Mar 2026
✓
Allotment
TBA
✓
Listing
30 Mar 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 26 Mar 2026 | ₹0.00 | - | 0.00% |
| 24 Mar 2026 | ₹0.00 | - | 0.00% |
| 23 Mar 2026 | ₹0.00 | - | 0.00% |
| 18 Mar 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,000 | ₹2,48,000 |
| Retail Maximum | 2 Lot | 2,000 | ₹2,48,000 |
| S-HNI Minimum | 3 Lot | 3,000 | ₹3,72,000 |
| S-HNI Maximum | 8 Lot | 8,000 | ₹9,92,000 |
| B-HNI Minimum | 9 Lot | 9,000 | ₹11,16,000 |
Analysis
IPO Details
| IPO Open Date | March 20, 2026 |
|---|---|
| IPO Close Date | March 24, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹117 to ₹124 Per Share |
| Issue Size | Approx ₹29.14 Crores |
| Fresh Issue | Approx ₹29.14 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | BSE SME |
Analysis
IPO Reservation
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 2% |
| NII Shares Offered | — Shares | 49% |
| Retail Shares Offered | — Shares | 49% |
Analysis
Speciality Medicines IPO Anchor Investors
| Anchor Bidding Date | 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Analysis
Speciality Medicines IPO Dates
| IPO Open Date | March 20, 2026 |
|---|---|
| IPO Close Date | March 24, 2026 |
| Basis of Allotment | March 25, 2026 |
| Refunds | March 27, 2026 |
| Credit to Demat Account | March 27, 2026 |
| IPO Listing Date | March 30, 2026 |
| Bidding Cut-off Time | March 24, 2026 – 5 PM |
Analysis
Promoters and Holding Pattern
| Promoters | Parth B Goyani and Goyani Sumit Babubhai |
|---|---|
| Promoter Holding Pre Issue | 64,35,796 Shares (59.28%) |
| Promoter Holding Post Issue | 87,85,796 Shares (43.44%) |
Analysis
Objects of the Issue & Utilisation of Proceeds
| Setting up of the Research and Development (R&D) Centre | ₹13.31 Cr. |
|---|---|
| Product registration in the international markets | ₹2.89 Cr. |
| Repayment / Prepayment of Borrowings | ₹1.75 Cr. |
| Working Capital Requirements | ₹12.00 Cr. |
| General Corporate Purpose | ₹— |
Analysis
Speciality Medicines IPO Company Financial Report
| Period Ended | Revenue (₹ Cr.) | Expense (₹ Cr.) | PAT (₹ Cr.) | Assets (₹ Cr.) |
|---|---|---|---|---|
| 2024 | 27.66 | 23.10 | 2.93 | 22.68 |
| 2025 | 58.54 | 49.85 | 8.61 | 39.98 |
| Oct 2025 | 36.93 | 30.80 | 6.06 | 45.57 |
Analysis
Speciality Medicines IPO Valuation – FY2025
| KPI | Values |
|---|---|
| ROE | 37.85% |
| ROCE | 33.39% |
| EBITDA Margin | 15.60% |
| PAT Margin | 14.77% |
| Debt to Equity Ratio | 0.17 |
| EPS (Basic) | ₹14.10 |
| P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 28.42% |
| Net Asset Value (NAV) | ₹47.07 |
Analysis
Peer Group Comparison
| Company | EPS | P/E Ratio | RoNW % | NAV | Income (₹ Cr.) |
|---|---|---|---|---|---|
| Remus Pharmaceuticals Limited | 65.21 | 12.25 | 15.02% | 434.25 | 620.36 |
| Trident Lifeline Limited | 10.22 | 27.59 | 18.23% | 56.05 | 86.96 |
| Mono Pharmacare Limited | 1.75 | 13.87 | 9.90% | 17.66 | 168.34 |
Analysis
IPO Lead Managers aka Merchant Bankers
- Unicon Capital Services Pvt. Ltd.
FAQ
Speciality Medicines IPO FAQs
Speciality Medicines IPO price band is Rs 117.00 to Rs 124.00. Check the latest issue price, lot size and GMP together before applying.
Speciality Medicines IPO open date is 20 Mar 2026, close date is 24 Mar 2026, and listing date is 30 Mar 2026.
Speciality Medicines IPO lot size is 1,000 shares. The minimum retail investment is Rs 2,48,000.
Speciality Medicines is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Speciality Medicines IPO subscription status currently shows Retail 0.85x, QIB 96.24x, Overall 2.27x.
Speciality Medicines IPO is an SME public issue of a pharmaceutical company engaged in the marketing and distribution of specialty medicines, including high-cost drugs used for chronic and complex diseases. The IPO aims to raise funds primarily for business expansion and working capital needs. The issue opened on 20 March 2026 and is expected to raise around ₹29 crore, with a neutral grey market sentiment (GMP ~ ₹0) indicating cautious investor interest before listing. With growing demand for advanced healthcare treatments and specialty drugs, the company operates in a niche but expanding segment of the pharmaceutical industry, offering potential long-term growth opportunities.
Speciality Medicines IPO issue size is TBA and the expected allotment date is TBA.
Keep Exploring
Similar Recent IPOs
Optimystix Entertainment India
Open • SME
Current GMP:
₹5
Listing Gain Est.
2.9%
Price Band
₹166.00 - ₹175.00
Lot Size
800 Shares
LAPL Automotive
Open • SME
Current GMP:
₹32
Listing Gain Est.
34.0%
Price Band
₹88.00 - ₹94.00
Lot Size
1,200 Shares
Aegeus Technologies
Closed • SME
Current GMP:
₹12
Listing Gain Est.
11.4%
Price Band
₹100.00 - ₹105.00
Lot Size
1,200 Shares
Anawil Wire and Engineering
Closed • SME
Current GMP:
₹80
Listing Gain Est.
29.6%
Price Band
₹257.00 - ₹270.00
Lot Size
400 Shares